Page 21 - Michael Erman News Today

The U.S. government will stop distributing free doses of Merck & Cos COVID-19 antiviral treatment molnupiravir by the middle of next month and expects it to be sold on the commercial market...

-Around 4 million Americans received the updated COVID-19 shots in September, according to the U.S. Department of Health and Human Services , even as some people have found it difficult to book... -October 04, 2023 at 04:56 pm EDT - MarketScreener

By Michael Erman (Reuters) - The U.S. government will stop distributing free doses of Merck & Co's COVID-19 antiviral treatment molnupiravir by the mi...

(Reuters) -Around 4 million Americans received the updated COVID-19 shots in September, according to the U.S. Department of Health and Human Services (HHS), even as some people have found it difficult to book vaccination appointments or find the vaccines at no cost. "The Biden-Harris Administration, through HHS, has been working directly with manufacturers and distributors to ensure that the vaccines are getting to pharmacies, hospitals, clinics, and other vaccination sites, including lon...

(Reuters) - Around 4 million Americans received the updated COVID-19 vaccines in September, according to a spokesperson for the U.S. Department of Hea...

(Reuters) - Around 4 million Americans received the updated COVID-19 vaccines in September, according to a spokesperson for the U.S. Department of Hea...

(Reuters) - Around 4 million Americans received the updated COVID-19 vaccines in September, according to a spokesperson for the U.S. Department of Hea...

(Reuters) - Around 4 million Americans received the updated COVID-19 vaccines in September, according to a spokesperson for the U.S. Department of Hea...

All the drugmakers that make the 10 prescription medicines subject to the first-ever price negotiations for the U.S. Medicare health program, including Amgen and Novartis, said they signed on...

By Michael Erman and Patrick Wingrove (Reuters) - All the drugmakers that make the 10 prescription medicines subject to the first-ever price negotiati...